Saudi Chemical starts manufacture, sale of ‘Panadol Extra’

20/11/2022 Argaam
Logo ofSaudi Chemical Holding Co.

Logo of Saudi Chemical Holding Co.

Saudi Chemical Holding Co. (SCCH) through its pharmaceutical sector, represented by AJA Pharmaceutical Industries Ltd. (AJA Pharma), started the initial manufacturing steps towards commercializing “Panadol Extra”, one of Haleon (GSK consumer healthcare) products.

 

The step consists of secondary packaging of the product at AJA Pharma manufacturing site, the company said in a statement on Tadawul, noting that the product is now available in the market.

 

The financial impact of the move will reflect on AJA Pharma’s Q4 2022 results, the statement added.

 

In June 2021, SCCH signed an agreement with GlaxoSmithKline Consumer Healthcare Saudi Ltd. to manufacture pharmaceutical products at AJA Pharma factory in Saudi Arabia, according to data compiled by Argaam.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.